Sign in

CIK 0001359931 · Non-accelerated filer<br>Smaller reporting company

Protara Therapeutics, Inc.

Sign in to watch
Ticker
TARA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Entity type
operating
EIN
204580525
Phone
646-844-0337
Business address
345 PARK AVENUE SOUTH, 3RD FLOOR, NEW YORK, NY, 10010
Former names
Protara Therapeutics, Inc., ArTara Therapeutics, Inc., PROTEON THERAPEUTICS INC
  1. 3 Insider Initial Statement of Ownership
  2. 3 Insider Initial Statement of Ownership
  3. 3 Insider Initial Statement of Ownership
  4. 3 Insider Initial Statement of Ownership
  5. 3 Insider Initial Statement of Ownership
  6. 3 Insider Initial Statement of Ownership
  7. CORRESP Other Correspondence Between Filers and SEC Staff
  8. CORRESP Other Correspondence Between Filers and SEC Staff
  9. 8-A12B Other Registration of Securities
  10. CERTNAS Other Certification by the Nasdaq Stock Market
  11. S-1/A Offering Registration Statement
  12. CORRESP Other Correspondence Between Filers and SEC Staff
  13. S-1 Offering Registration Statement
  14. UPLOAD Other SEC-generated Letter
  15. DRSLTR Other Correspondence Related to Draft Registration Statement
  16. DRSLTR Other Correspondence Related to Draft Registration Statement
  17. DRS/A Other Draft Registration Statement
  18. UPLOAD Other SEC-generated Letter
  19. DRS/A Other Draft Registration Statement
  20. DRSLTR Other Correspondence Related to Draft Registration Statement

Page 40 of 41 · 811 filings